Evidence map›Paper›PMID 39211906›Full record

ArticleGenes & diseases2024

A novel homozygous intronic variant affecting splicing in the

Wei Hou, Guifang Huang, Hongyu Wei, Wenwei Li, Houfeng Huang, Yuling Qiu, Hengying Zhu, Huifeng Han, Ping Chen, Xue Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes & diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. BiallelicFrontiers in endocrinology · 2026
    Article
  2. Multilocus pathogenic variants inAME case reports · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wei HouCollaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, Guangxi 530021, China.
Guifang HuangDepartment of Eugenic Genetics, Baise Maternal and Child Health Hospital, Baise, Guangxi 533000, China.
Hongyu WeiDepartment of Organic Chemistry and Medicinal Chemistry, Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi 530021, China.
Wenwei LiNHC Key Laboratory of Thalassemia Medicine, Nanning, Guangxi 530021, China.
Houfeng HuangDepartment of Ultrasound Imaging, Baise Maternal and Child Health Hospital, Baise, Guangxi 533000, China.
Yuling QiuNHC Key Laboratory of Thalassemia Medicine, Nanning, Guangxi 530021, China.
Hengying ZhuNHC Key Laboratory of Thalassemia Medicine, Nanning, Guangxi 530021, China.
Huifeng HanDepartment of Bioinformatics, Berry Genomics Co., Ltd., Beijing 102206, China.
Ping ChenNHC Key Laboratory of Thalassemia Medicine, Nanning, Guangxi 530021, China.
Xue ZhangCollaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, Guangxi 530021, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39211906
PMCPMC11359738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.